 | • レポートコード：MRC2-11QY11094 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は生体吸収性冠動脈ステントのグローバル市場について調査・分析したレポートです。種類別（アブゾーブBVS、アブゾーブ第二世代BVS、マグマリス、MeRes-100、DESolve）市場規模、用途別（病院、クリニック、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別生体吸収性冠動脈ステントの競争状況、市場シェア ・世界の生体吸収性冠動脈ステント市場：種類別市場規模 2015年-2020年（アブゾーブBVS、アブゾーブ第二世代BVS、マグマリス、MeRes-100、DESolve） ・世界の生体吸収性冠動脈ステント市場：種類別市場規模予測 2021年-2026年（アブゾーブBVS、アブゾーブ第二世代BVS、マグマリス、MeRes-100、DESolve） ・世界の生体吸収性冠動脈ステント市場：用途別市場規模 2015年-2020年（病院、クリニック、研究所） ・世界の生体吸収性冠動脈ステント市場：用途別市場規模予測 2021年-2026年（病院、クリニック、研究所） ・北米の生体吸収性冠動脈ステント市場分析：米国、カナダ ・ヨーロッパの生体吸収性冠動脈ステント市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの生体吸収性冠動脈ステント市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の生体吸収性冠動脈ステント市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの生体吸収性冠動脈ステント市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：BIOTRONIK、Meril Lifesciences Pvt. Ltd.、Elixir Medical Corporation、REVA Medical、Arterial Remodeling Technologies、Amaranth Medical、Microport Scientific Corporation ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Placement of these bioresorbable devices enable individuals to live with a normal functioning artery as well as the option to undergo an angioplasty in their later years. While still in development stage, the pediatric patient cohort with genetic coronary conditions are a viable target for these fully dissolvable stents that allow restoration of normal vasomotor function as well as normal vessel growth.
APAC is expected to witness the fastest growth with a CAGR of 21%. Apart from increasing coronary stenting procedure volumes that stem from the high CVD-afflicted patient count, this region witnesses quick uptake of CE and FDA-approved devices, which in turn is engendering the high sales revenue of bioresorbable coronary stents in this regional segment.
Market Analysis and Insights: Global Bioresorbable Coronary Stents Market
The global Bioresorbable Coronary Stents market size is projected to reach US$ 88 million by 2026, from US$ 81 million in 2020, at a CAGR of 8.5%% during 2021-2026.
Global Bioresorbable Coronary Stents Scope and Market Size
Bioresorbable Coronary Stents market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bioresorbable Coronary Stents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
BIOTRONIK
Meril Lifesciences Pvt. Ltd.
Elixir Medical Corporation
REVA Medical
Arterial Remodeling Technologies
Amaranth Medical
Microport Scientific Corporation
…
Market segment by Type, the product can be split into
Absorb BVS
Absorb 2nd Generation
Magmaris
MeRes-100
DESolve
Market segment by Application, split into
Hospital
Clinic
Research Institute
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bioresorbable Coronary Stents Revenue
1.4 Market by Type
1.4.1 Global Bioresorbable Coronary Stents Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Absorb BVS
1.4.3 Absorb 2nd Generation
1.4.4 Magmaris
1.4.5 MeRes-100
1.4.6 DESolve
1.5 Market by Application
1.5.1 Global Bioresorbable Coronary Stents Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Research Institute
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Bioresorbable Coronary Stents Market Perspective (2015-2026)
2.2 Global Bioresorbable Coronary Stents Growth Trends by Regions
2.2.1 Bioresorbable Coronary Stents Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Bioresorbable Coronary Stents Historic Market Share by Regions (2015-2020)
2.2.3 Bioresorbable Coronary Stents Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Bioresorbable Coronary Stents Market Growth Strategy
2.3.6 Primary Interviews with Key Bioresorbable Coronary Stents Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Bioresorbable Coronary Stents Players by Market Size
3.1.1 Global Top Bioresorbable Coronary Stents Players by Revenue (2015-2020)
3.1.2 Global Bioresorbable Coronary Stents Revenue Market Share by Players (2015-2020)
3.1.3 Global Bioresorbable Coronary Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bioresorbable Coronary Stents Market Concentration Ratio
3.2.1 Global Bioresorbable Coronary Stents Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Bioresorbable Coronary Stents Revenue in 2019
3.3 Bioresorbable Coronary Stents Key Players Head office and Area Served
3.4 Key Players Bioresorbable Coronary Stents Product Solution and Service
3.5 Date of Enter into Bioresorbable Coronary Stents Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bioresorbable Coronary Stents Historic Market Size by Type (2015-2020)
4.2 Global Bioresorbable Coronary Stents Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Bioresorbable Coronary Stents Market Size by Application (2015-2020)
5.2 Global Bioresorbable Coronary Stents Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Bioresorbable Coronary Stents Market Size (2015-2020)
6.2 Bioresorbable Coronary Stents Key Players in North America (2019-2020)
6.3 North America Bioresorbable Coronary Stents Market Size by Type (2015-2020)
6.4 North America Bioresorbable Coronary Stents Market Size by Application (2015-2020)
7 Europe
7.1 Europe Bioresorbable Coronary Stents Market Size (2015-2020)
7.2 Bioresorbable Coronary Stents Key Players in Europe (2019-2020)
7.3 Europe Bioresorbable Coronary Stents Market Size by Type (2015-2020)
7.4 Europe Bioresorbable Coronary Stents Market Size by Application (2015-2020)
8 China
8.1 China Bioresorbable Coronary Stents Market Size (2015-2020)
8.2 Bioresorbable Coronary Stents Key Players in China (2019-2020)
8.3 China Bioresorbable Coronary Stents Market Size by Type (2015-2020)
8.4 China Bioresorbable Coronary Stents Market Size by Application (2015-2020)
9 Japan
9.1 Japan Bioresorbable Coronary Stents Market Size (2015-2020)
9.2 Bioresorbable Coronary Stents Key Players in Japan (2019-2020)
9.3 Japan Bioresorbable Coronary Stents Market Size by Type (2015-2020)
9.4 Japan Bioresorbable Coronary Stents Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Bioresorbable Coronary Stents Market Size (2015-2020)
10.2 Bioresorbable Coronary Stents Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bioresorbable Coronary Stents Market Size by Type (2015-2020)
10.4 Southeast Asia Bioresorbable Coronary Stents Market Size by Application (2015-2020)
11 India
11.1 India Bioresorbable Coronary Stents Market Size (2015-2020)
11.2 Bioresorbable Coronary Stents Key Players in India (2019-2020)
11.3 India Bioresorbable Coronary Stents Market Size by Type (2015-2020)
11.4 India Bioresorbable Coronary Stents Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Bioresorbable Coronary Stents Market Size (2015-2020)
12.2 Bioresorbable Coronary Stents Key Players in Central & South America (2019-2020)
12.3 Central & South America Bioresorbable Coronary Stents Market Size by Type (2015-2020)
12.4 Central & South America Bioresorbable Coronary Stents Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 BIOTRONIK
13.1.1 BIOTRONIK Company Details
13.1.2 BIOTRONIK Business Overview
13.1.3 BIOTRONIK Bioresorbable Coronary Stents Introduction
13.1.4 BIOTRONIK Revenue in Bioresorbable Coronary Stents Business (2015-2020))
13.1.5 BIOTRONIK Recent Development
13.2 Meril Lifesciences Pvt. Ltd.
13.2.1 Meril Lifesciences Pvt. Ltd. Company Details
13.2.2 Meril Lifesciences Pvt. Ltd. Business Overview
13.2.3 Meril Lifesciences Pvt. Ltd. Bioresorbable Coronary Stents Introduction
13.2.4 Meril Lifesciences Pvt. Ltd. Revenue in Bioresorbable Coronary Stents Business (2015-2020)
13.2.5 Meril Lifesciences Pvt. Ltd. Recent Development
13.3 Elixir Medical Corporation
13.3.1 Elixir Medical Corporation Company Details
13.3.2 Elixir Medical Corporation Business Overview
13.3.3 Elixir Medical Corporation Bioresorbable Coronary Stents Introduction
13.3.4 Elixir Medical Corporation Revenue in Bioresorbable Coronary Stents Business (2015-2020)
13.3.5 Elixir Medical Corporation Recent Development
13.4 REVA Medical
13.4.1 REVA Medical Company Details
13.4.2 REVA Medical Business Overview
13.4.3 REVA Medical Bioresorbable Coronary Stents Introduction
13.4.4 REVA Medical Revenue in Bioresorbable Coronary Stents Business (2015-2020)
13.4.5 REVA Medical Recent Development
13.5 Arterial Remodeling Technologies
13.5.1 Arterial Remodeling Technologies Company Details
13.5.2 Arterial Remodeling Technologies Business Overview
13.5.3 Arterial Remodeling Technologies Bioresorbable Coronary Stents Introduction
13.5.4 Arterial Remodeling Technologies Revenue in Bioresorbable Coronary Stents Business (2015-2020)
13.5.5 Arterial Remodeling Technologies Recent Development
13.6 Amaranth Medical
13.6.1 Amaranth Medical Company Details
13.6.2 Amaranth Medical Business Overview
13.6.3 Amaranth Medical Bioresorbable Coronary Stents Introduction
13.6.4 Amaranth Medical Revenue in Bioresorbable Coronary Stents Business (2015-2020)
13.6.5 Amaranth Medical Recent Development
13.7 Microport Scientific Corporation
13.7.1 Microport Scientific Corporation Company Details
13.7.2 Microport Scientific Corporation Business Overview
13.7.3 Microport Scientific Corporation Bioresorbable Coronary Stents Introduction
13.7.4 Microport Scientific Corporation Revenue in Bioresorbable Coronary Stents Business (2015-2020)
13.7.5 Microport Scientific Corporation Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Bioresorbable Coronary Stents Key Market Segments
Table 2. Key Players Covered: Ranking by Bioresorbable Coronary Stents Revenue
Table 3. Ranking of Global Top Bioresorbable Coronary Stents Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Bioresorbable Coronary Stents Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Absorb BVS
Table 6. Key Players of Absorb 2nd Generation
Table 7. Key Players of Magmaris
Table 8. Key Players of MeRes-100
Table 9. Key Players of DESolve
Table 10. Global Bioresorbable Coronary Stents Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Bioresorbable Coronary Stents Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Bioresorbable Coronary Stents Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Bioresorbable Coronary Stents Market Share by Regions (2015-2020)
Table 14. Global Bioresorbable Coronary Stents Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Bioresorbable Coronary Stents Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Bioresorbable Coronary Stents Market Growth Strategy
Table 20. Main Points Interviewed from Key Bioresorbable Coronary Stents Players
Table 21. Global Bioresorbable Coronary Stents Revenue by Players (2015-2020) (Million US$)
Table 22. Global Bioresorbable Coronary Stents Market Share by Players (2015-2020)
Table 23. Global Top Bioresorbable Coronary Stents Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bioresorbable Coronary Stents as of 2019)
Table 24. Global Bioresorbable Coronary Stents by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Bioresorbable Coronary Stents Product Solution and Service
Table 27. Date of Enter into Bioresorbable Coronary Stents Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Bioresorbable Coronary Stents Market Size by Type (2015-2020) (Million US$)
Table 30. Global Bioresorbable Coronary Stents Market Size Share by Type (2015-2020)
Table 31. Global Bioresorbable Coronary Stents Revenue Market Share by Type (2021-2026)
Table 32. Global Bioresorbable Coronary Stents Market Size Share by Application (2015-2020)
Table 33. Global Bioresorbable Coronary Stents Market Size by Application (2015-2020) (Million US$)
Table 34. Global Bioresorbable Coronary Stents Market Size Share by Application (2021-2026)
Table 35. North America Key Players Bioresorbable Coronary Stents Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Bioresorbable Coronary Stents Market Share (2019-2020)
Table 37. North America Bioresorbable Coronary Stents Market Size by Type (2015-2020) (Million US$)
Table 38. North America Bioresorbable Coronary Stents Market Share by Type (2015-2020)
Table 39. North America Bioresorbable Coronary Stents Market Size by Application (2015-2020) (Million US$)
Table 40. North America Bioresorbable Coronary Stents Market Share by Application (2015-2020)
Table 41. Europe Key Players Bioresorbable Coronary Stents Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Bioresorbable Coronary Stents Market Share (2019-2020)
Table 43. Europe Bioresorbable Coronary Stents Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Bioresorbable Coronary Stents Market Share by Type (2015-2020)
Table 45. Europe Bioresorbable Coronary Stents Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Bioresorbable Coronary Stents Market Share by Application (2015-2020)
Table 47. China Key Players Bioresorbable Coronary Stents Revenue (2019-2020) (Million US$)
Table 48. China Key Players Bioresorbable Coronary Stents Market Share (2019-2020)
Table 49. China Bioresorbable Coronary Stents Market Size by Type (2015-2020) (Million US$)
Table 50. China Bioresorbable Coronary Stents Market Share by Type (2015-2020)
Table 51. China Bioresorbable Coronary Stents Market Size by Application (2015-2020) (Million US$)
Table 52. China Bioresorbable Coronary Stents Market Share by Application (2015-2020)
Table 53. Japan Key Players Bioresorbable Coronary Stents Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Bioresorbable Coronary Stents Market Share (2019-2020)
Table 55. Japan Bioresorbable Coronary Stents Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Bioresorbable Coronary Stents Market Share by Type (2015-2020)
Table 57. Japan Bioresorbable Coronary Stents Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Bioresorbable Coronary Stents Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Bioresorbable Coronary Stents Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Bioresorbable Coronary Stents Market Share (2019-2020)
Table 61. Southeast Asia Bioresorbable Coronary Stents Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Bioresorbable Coronary Stents Market Share by Type (2015-2020)
Table 63. Southeast Asia Bioresorbable Coronary Stents Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Bioresorbable Coronary Stents Market Share by Application (2015-2020)
Table 65. India Key Players Bioresorbable Coronary Stents Revenue (2019-2020) (Million US$)
Table 66. India Key Players Bioresorbable Coronary Stents Market Share (2019-2020)
Table 67. India Bioresorbable Coronary Stents Market Size by Type (2015-2020) (Million US$)
Table 68. India Bioresorbable Coronary Stents Market Share by Type (2015-2020)
Table 69. India Bioresorbable Coronary Stents Market Size by Application (2015-2020) (Million US$)
Table 70. India Bioresorbable Coronary Stents Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Bioresorbable Coronary Stents Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Bioresorbable Coronary Stents Market Share (2019-2020)
Table 73. Central & South America Bioresorbable Coronary Stents Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Bioresorbable Coronary Stents Market Share by Type (2015-2020)
Table 75. Central & South America Bioresorbable Coronary Stents Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Bioresorbable Coronary Stents Market Share by Application (2015-2020)
Table 77. BIOTRONIK Company Details
Table 78. BIOTRONIK Business Overview
Table 79. BIOTRONIK Product
Table 80. BIOTRONIK Revenue in Bioresorbable Coronary Stents Business (2015-2020) (Million US$)
Table 81. BIOTRONIK Recent Development
Table 82. Meril Lifesciences Pvt. Ltd. Company Details
Table 83. Meril Lifesciences Pvt. Ltd. Business Overview
Table 84. Meril Lifesciences Pvt. Ltd. Product
Table 85. Meril Lifesciences Pvt. Ltd. Revenue in Bioresorbable Coronary Stents Business (2015-2020) (Million US$)
Table 86. Meril Lifesciences Pvt. Ltd. Recent Development
Table 87. Elixir Medical Corporation Company Details
Table 88. Elixir Medical Corporation Business Overview
Table 89. Elixir Medical Corporation Product
Table 90. Elixir Medical Corporation Revenue in Bioresorbable Coronary Stents Business (2015-2020) (Million US$)
Table 91. Elixir Medical Corporation Recent Development
Table 92. REVA Medical Company Details
Table 93. REVA Medical Business Overview
Table 94. REVA Medical Product
Table 95. REVA Medical Revenue in Bioresorbable Coronary Stents Business (2015-2020) (Million US$)
Table 96. REVA Medical Recent Development
Table 97. Arterial Remodeling Technologies Company Details
Table 98. Arterial Remodeling Technologies Business Overview
Table 99. Arterial Remodeling Technologies Product
Table 100. Arterial Remodeling Technologies Revenue in Bioresorbable Coronary Stents Business (2015-2020) (Million US$)
Table 101. Arterial Remodeling Technologies Recent Development
Table 102. Amaranth Medical Company Details
Table 103. Amaranth Medical Business Overview
Table 104. Amaranth Medical Product
Table 105. Amaranth Medical Revenue in Bioresorbable Coronary Stents Business (2015-2020) (Million US$)
Table 106. Amaranth Medical Recent Development
Table 107. Microport Scientific Corporation Company Details
Table 108. Microport Scientific Corporation Business Overview
Table 109. Microport Scientific Corporation Product
Table 110. Microport Scientific Corporation Revenue in Bioresorbable Coronary Stents Business (2015-2020) (Million US$)
Table 111. Microport Scientific Corporation Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bioresorbable Coronary Stents Market Share by Type: 2020 VS 2026
Figure 2. Absorb BVS Features
Figure 3. Absorb 2nd Generation Features
Figure 4. Magmaris Features
Figure 5. MeRes-100 Features
Figure 6. DESolve Features
Figure 7. Global Bioresorbable Coronary Stents Market Share by Application: 2020 VS 2026
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Research Institute Case Studies
Figure 11. Bioresorbable Coronary Stents Report Years Considered
Figure 12. Global Bioresorbable Coronary Stents Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Bioresorbable Coronary Stents Market Share by Regions: 2020 VS 2026
Figure 14. Global Bioresorbable Coronary Stents Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Bioresorbable Coronary Stents Market Share by Players in 2019
Figure 17. Global Top Bioresorbable Coronary Stents Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bioresorbable Coronary Stents as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Bioresorbable Coronary Stents Revenue in 2019
Figure 19. North America Bioresorbable Coronary Stents Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Bioresorbable Coronary Stents Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Bioresorbable Coronary Stents Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Bioresorbable Coronary Stents Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Bioresorbable Coronary Stents Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Bioresorbable Coronary Stents Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Bioresorbable Coronary Stents Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
経皮的冠動脈インターベンションの世界市場（～2026年） Percutaneous coronary intervention (PCI) is a non-surgical procedure used to treat narrowing (stenosis) of the coronary arteries of the heart found in coronary artery disease. After accessing the blood stream through the femoral or radial artery, the procedure uses coronary catheterization to visual…- 急性冠症候群（ACS）の世界市場（～2026年） Acute coronary syndrome (ACS) is a syndrome (set of signs and symptoms) due to decreased blood flow in the coronary arteries such that part of the heart muscle is unable to function properly or dies. The most common symptom is chest pain, often radiating to the left shoulder or angle of the jaw, cru…
- 薬剤溶出性生体吸収性ステントの世界市場（～2026年） Market Analysis and Insights: Global Drug-Eluting Bioabsorbable Stents Market The global Drug-Eluting Bioabsorbable Stents market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Drug-Eluting Bioabsorbable Stents Scope and Mar…
- 冠動脈画像の世界市場（～2026年） Coronary Artery disease (CAD) is a cardiovascular disorder which is caused by reduced flow or absent of blood flow in arteries that enclose and supply the heart which is commonly known as Ischemia. Usually in a coronary artery, due to deposition of fat, cholesterol, and calcium forms a thick layer i…
- 冠動脈疾患治療薬の世界市場（～2026年） Coronary artery disease (CAD), also known as ischemic heart disease (IHD), refers to a group of diseases which includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death. Our research analysis on the global coronary artery disease therapeutics market has identified that…